SIGA · Siga Technologies Inc
$3.04
+0.07 (+2.36%)
At close · Aug 21
Market Cap
$218.42M
Shares
71.85M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$94.57M
-31.8%
FY2025
Net Income
$23.28M
-60.7%
FY2025
Gross Margin
68.59%
-8.8pp
FY2025
Operating Margin
25.06%
-25.4pp
FY2025
Diluted EPS
$0.32
-61%
FY2025
Operating Cash Flow
$43.47M
-10.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $53.66M | $94.57M | $138.72M | $139.92MG | $110.78M | $133.67M | $124.96M | $26.74M | $477.05M | $12.27M | $14.99M | — | — | — | — | — | — | — | |
| $24.49M | $29.7M | $31.29M | $17.83M | $10.43M | $16.6M | $14.8M | $1.78M | $95.27M | $0 | $0 | — | — | — | — | — | — | — | |
| $29.17M | $64.87M | $107.43M | $122.09M | $100.34M | $117.07M | $110.16M | $24.96M | $381.78M | $12.27M | $14.99M | — | — | — | — | — | — | — | |
| — | 68.59% | 77.44% | 87.26% | 90.58% | 87.58% | 88.16% | 93.33% | 80.03% | 100% | 100% | — | — | — | — | — | — | — | |
| $20.43M | $19.96M | $12.31M | $16.43M | $22.53M | $9.94M | $10.94M | $13.3M | $13.02M | $16.68M | $19.71M | $13.13M | $10.71M | $13.79M | $18.21M | $18.37M | $22.66M | $17.42M | |
| $19.87M | $21.21M | $25.14M | $22.04M | $35.12M | $18.03M | $14.72M | $13.25M | $12.88M | $12.3M | $13.71M | $10.58M | $12.65M | $13.12M | $10.97M | $23.93M | $8.13M | $7.53M | |
| — | $562.61K | $538.42K | $538.29K | $517.64K | $522.37K | $529.81K | $527K | $69.63K | $132.19K | $174.28K | $247.36K | $351.56K | $463.14K | $419.36K | $568.29K | $625.34K | $475.09K | |
| — | — | — | — | — | — | — | — | — | — | — | $0 | $0 | $512.94K | $0 | $0 | — | — | |
| — | — | — | — | — | — | — | $29.06M | $121.95M | $31.12M | $46M | $39.13M | $212.81M | $29.04M | $31.51M | $44.11M | $31.94M | $25.69M | |
| $64.8M | $70.87M | $68.74M | $56.3M | $68.08M | $44.58M | $40.46M | $29.06M | $121.95M | — | — | — | — | — | — | — | — | — | |
| -$11.14M | $23.7M | $69.98M | $83.62M | $42.7M | $89.09M | $84.5M | -$2.32M | $355.1M | -$18.85M | -$31.01M | -$30.95M | -$209.67M | -$23.52M | -$22.54M | -$31.38M | -$12.72M | -$11.88M | |
| — | 25.06% | 50.45% | 59.76% | 38.55% | 66.65% | 67.62% | -8.68% | 74.44% | -153.63% | -206.94% | — | — | — | — | — | — | — | |
| — | $24.26M | $70.52M | $84.16M | $43.22M | $89.62M | $85.03M | -$1.8M | $355.17M | -$18.72M | -$30.84M | -$30.71M | -$209.32M | -$23.05M | -$22.12M | -$30.81M | -$12.1M | -$11.4M | |
| — | — | — | — | $0 | $0 | $3.02M | $15.77M | $15.48M | $14.76M | $2.4M | $266.73K | $455.81K | $1.21M | $172.99K | $0 | $0 | — | |
| $5.63M | $6.68M | $6.09M | $4.16M | $1.03M | $101.17K | $532.09K | $2.82M | $78.94M | $16.79K | $102.32K | $42.2K | $1065 | $1497 | $522 | $13.06K | $659.29K | $1437 | |
| -$5.51M | $30.38M | $76.07M | $87.78M | $44.13M | $89.31M | $73.51M | -$10.18M | $411.64M | -$38.33M | -$39.68M | -$38.99M | -$211.93M | -$24.8M | -$21.9M | -$6.93M | -$50.17M | -$19.4M | |
| -$2.72M | $7.1M | $16.86M | $19.71M | $10.23M | $19.86M | $17.17M | -$2.94M | -$10.17M | -$2.09M | $13.88K | $461.98K | $53.53M | -$7.62M | -$7.84M | -$36.03M | $175.18K | $0 | |
| -$2.79M | $23.28M | $59.21M | $68.07M | $33.9M | $69.45M | $56.34M | -$7.24M | $421.81M | -$36.24M | -$39.7M | -$39.45M | -$265.46M | -$17.18M | -$14.06M | $29.1M | -$50.35M | -$19.4M | |
| — | 24.61% | 42.69% | 48.65% | 30.61% | 51.96% | 45.09% | -27.08% | 88.42% | -295.34% | -264.87% | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | -$17.18M | -$14.06M | $29.1M | -$50.34M | — | |
| USD/shares | — | $0.33 | $0.83 | $0.95 | $0.46 | $0.92 | $0.71 | -$0.09 | $5.28 | -$0.46 | -$0.69 | -$0.73 | -$4.97 | -$0.33 | -$0.27 | $0.57 | -$1.12 | -$0.52 |
| USD/shares | — | $0.32 | $0.82 | $0.95 | $0.46 | $0.91 | $0.71 | -$0.15 | $5.18 | -$0.46 | -$0.69 | -$0.73 | -$4.97 | -$0.33 | -$0.27 | $0.09 | -$1.12 | -$0.52 |
| shares | — | 71.53M | 71.25M | 71.36M | 72.93M | 75.32M | 79.26M | 81.03M | 79.92M | 78.87M | 57.19M | 53.78M | 53.42M | 52.37M | 51.64M | 50.93M | 45.15M | 37.46M |
| shares | — | 71.87M | 71.91M | 71.68M | 73.55M | 76.4M | 79.44M | 82.18M | 82.71M | 78.87M | 57.19M | 53.78M | 53.42M | 52.37M | 51.64M | 54.06M | 45.15M | 37.46M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2025: $80.04M in buybacks, $150.86M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.47×
EV/EBIT
—
Peer median 11.98×
P/E (TTM)
—
Peer median 12.78×
Peer medians compare against the 56 similar-size Drug Manufacturers - Specialty & Generic companies (of 104 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| United States | $88,753,655 | $115,743,994 | $118,650,253 | $39,803,888 | $120,656,294 | $122,416,481 |
| Canada | $5,821,247 | $737,677 | $0 | $38,875,657 | $13,014,160 | $2,542,823 |
| Non Us | $5,821,247 | $22,975,356 | $21,266,967 | $70,971,722 | $13,014,160 | $2,542,823 |
| Asia Pacific | $0 | $13,857,043 | $966,633 | $14,853,233 | $0 | $0 |
| EMEA | $0 | $8,380,636 | $20,300,334 | $16,270,033 | $0 | $0 |
| Other | — | $0 | $0 | $972,799 | $0 | $0 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Product Sales and Supportive Services | $88,048,145 | $133,330,181 | $130,668,209 | $86,661,583 | $126,802,536 | $115,471,071 | $11,190,064 | $468,918,468 |
| Research and Development | $6,526,757 | $5,389,169 | $9,249,011 | $24,114,027 | $6,867,918 | $9,488,233 | $15,552,021 | $8,135,314 |
Key facts
CIK
1010086
CUSIP
826917106
13F (30d)
138 filings
138 filers
Visit website
Investor relations